DB05726InvestigationalSmall molecule
AVI-526 is an improved formulation of AVI-4557, developed for use on Vein Grafts before use in Heart by-Pass Graft Surgery. AVI-526 works by silencing a gene known as c-myc, a... The drug was under investigation in clinical trial NCT00451256 (Safety and Efficacy Study of AVI-5126 When Used on Vein Grafts Before Use in Heart by-Pass Graft Surgery (CABG)).
- Primary indication
- Investigated for use/treatment in coronary artery disease.Curator reviewed
- Also known as
- Resten-CP · Resten-CP(TM)
- Code names
- AVI-5126
What you can answer from here — as of April 02, 2025
Which companies are running trials of AVI-5126, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account